148 related articles for article (PubMed ID: 16133365)
21. Toll-like Receptor 2 Signalling and the Lysosomal Machinery in Barrett's Esophagus.
Verbeek RE; Siersema PD; Vleggaar FP; Ten Kate FJ; Posthuma G; Souza RF; de Haan J; van Baal JW
J Gastrointestin Liver Dis; 2016 Sep; 25(3):273-82. PubMed ID: 27689189
[TBL] [Abstract][Full Text] [Related]
22. Nuclear localization of Toll-like receptor 5 in Barrett's esophagus and esophageal adenocarcinoma is associated with metastatic behavior.
Helminen O; Huhta H; Leppänen J; Kauppila JH; Takala H; Lehenkari PP; Saarnio J; Karttunen TJ
Virchows Arch; 2016 Oct; 469(4):465-70. PubMed ID: 27392931
[TBL] [Abstract][Full Text] [Related]
23. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
Chatelain D; Fléjou JF
Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
[TBL] [Abstract][Full Text] [Related]
24. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
Feith M; Stein HJ; Mueller J; Siewert JR
Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
[TBL] [Abstract][Full Text] [Related]
25. A multigene expression panel for the molecular diagnosis of Barrett's esophagus and Barrett's adenocarcinoma of the esophagus.
Brabender J; Marjoram P; Salonga D; Metzger R; Schneider PM; Park JM; Schneider S; Hölscher AH; Yin J; Meltzer SJ; Danenberg KD; Danenberg PV; Lord RV
Oncogene; 2004 Jun; 23(27):4780-8. PubMed ID: 15107828
[TBL] [Abstract][Full Text] [Related]
26. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation.
Bailey T; Biddlestone L; Shepherd N; Barr H; Warner P; Jankowski J
Am J Pathol; 1998 Jan; 152(1):135-44. PubMed ID: 9422531
[TBL] [Abstract][Full Text] [Related]
27. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D receptor is highly expressed in precancerous lesions and esophageal adenocarcinoma with significant sex difference.
Zhou Z; Xia Y; Bandla S; Zakharov V; Wu S; Peters J; Godfrey TE; Sun J
Hum Pathol; 2014 Aug; 45(8):1744-51. PubMed ID: 24951052
[TBL] [Abstract][Full Text] [Related]
29. Decrease in Le(x) expression in esophageal adenocarcinomas arising in Barrett's epithelium.
Engel U; McCombs R; Stranahan P; Pettijohn D; Hage E
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):245-8. PubMed ID: 9107429
[TBL] [Abstract][Full Text] [Related]
30. Rab11 in dysplasia of Barrett's epithelia.
Goldenring JR; Ray GS; Lee JR
Yale J Biol Med; 1999; 72(2-3):113-20. PubMed ID: 10780572
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical analysis of selected molecular markers in esophagus precancerous, adenocarcinoma and squamous cell carcinoma in Iranian subjects.
Allameh A; Rasmi Y; Nasseri-Moghaddam S; Tavangar SM; Sharifi R; Sadreddini M
Cancer Epidemiol; 2009 Jul; 33(1):79-84. PubMed ID: 19679052
[TBL] [Abstract][Full Text] [Related]
32. The renin-angiotensin system in Barrett's esophagus.
Bratlie SO; Edebo A; Casselbrant A; Helander HF; Fändriks L
Scand J Gastroenterol; 2016 Sep; 51(9):1037-42. PubMed ID: 27174460
[TBL] [Abstract][Full Text] [Related]
33. Cdx1 and c-Myc foster the initiation of transdifferentiation of the normal esophageal squamous epithelium toward Barrett's esophagus.
Stairs DB; Nakagawa H; Klein-Szanto A; Mitchell SD; Silberg DG; Tobias JW; Lynch JP; Rustgi AK
PLoS One; 2008; 3(10):e3534. PubMed ID: 18953412
[TBL] [Abstract][Full Text] [Related]
34. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
[TBL] [Abstract][Full Text] [Related]
35. Bile acid-induced expression of activation-induced cytidine deaminase during the development of Barrett's oesophageal adenocarcinoma.
Morita S; Matsumoto Y; Okuyama S; Ono K; Kitamura Y; Tomori A; Oyama T; Amano Y; Kinoshita Y; Chiba T; Marusawa H
Carcinogenesis; 2011 Nov; 32(11):1706-12. PubMed ID: 21890457
[TBL] [Abstract][Full Text] [Related]
36. Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.
Zou H; Osborn NK; Harrington JJ; Klatt KK; Molina JR; Burgart LJ; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):830-4. PubMed ID: 15824152
[TBL] [Abstract][Full Text] [Related]
37. p16 expression in Barrett's esophagus and esophageal adenocarcinoma: association with genetic and epigenetic alterations.
Hardie LJ; Darnton SJ; Wallis YL; Chauhan A; Hainaut P; Wild CP; Casson AG
Cancer Lett; 2005 Jan; 217(2):221-30. PubMed ID: 15617840
[TBL] [Abstract][Full Text] [Related]
38. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
[TBL] [Abstract][Full Text] [Related]
39. [A study on cyclooxygenase-2 protein expression in esophageal carcinoma and premalignant lesions].
Wang L; Zhang W; Wang W
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):14-6. PubMed ID: 11783060
[TBL] [Abstract][Full Text] [Related]
40. The molecular signature of normal squamous esophageal epithelium identifies the presence of a field effect and can discriminate between patients with Barrett's esophagus and patients with Barrett's-associated adenocarcinoma.
Brabender J; Marjoram P; Lord RV; Metzger R; Salonga D; Vallböhmer D; Schäfer H; Danenberg KD; Danenberg PV; Selaru FM; Baldus SE; Hölscher AH; Meltzer SJ; Schneider PM
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2113-7. PubMed ID: 16172218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
